A citation-based method for searching scientific literature

Alessandra Giavarini, Ranil de Silva. Cardiovasc Drugs Ther 2016
Times Cited: 4







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Optimal medical therapy with or without PCI for stable coronary disease.
William E Boden, Robert A O'Rourke, Koon K Teo, Pamela M Hartigan, David J Maron, William J Kostuk, Merril Knudtson, Marcin Dada, Paul Casperson, Crystal L Harris,[...]. N Engl J Med 2007
50

Beta-Blockers and Calcium Channel Blockers: First Line Agents.
Isaac Pascual, Cesar Moris, Pablo Avanzas. Cardiovasc Drugs Ther 2016
7
25

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
Dariush Mozaffarian, Emelia J Benjamin, Alan S Go, Donna K Arnett, Michael J Blaha, Mary Cushman, Sandeep R Das, Sarah de Ferranti, Jean-Pierre Després, Heather J Fullerton,[...]. Circulation 2016
25

Overview of Management of Myocardial Ischemia: a Mechanistic-Based Approach.
Gaetano Antonio Lanza, Filippo Crea. Cardiovasc Drugs Ther 2016
5
25

Vasodilator Therapy: Nitrates and Nicorandil.
Jason M Tarkin, Juan Carlos Kaski. Cardiovasc Drugs Ther 2016
36
25

Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
Giuseppe M C Rosano, Cristiana Vitale, Maurizio Volterrani. Cardiovasc Drugs Ther 2016
5
25

Drugs that Affect Cardiac Metabolism: Focus on Perhexiline.
Cher-Rin Chong, Benedetta Sallustio, John D Horowitz. Cardiovasc Drugs Ther 2016
15
25

Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.
Lokien X van Nunen, Frederik M Zimmermann, Pim A L Tonino, Emanuele Barbato, Andreas Baumbach, Thomas Engstrøm, Volker Klauss, Philip A MacCarthy, Ganesh Manoharan, Keith G Oldroyd,[...]. Lancet 2015
263
25

Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update.
Giacinta Guarini, Alda Huqi, Doralisa Morrone, Mario Marzilli. Cardiovasc Drugs Ther 2016
8
25


Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction.
Peter Ong, Anastasios Athanasiadis, Udo Sechtem. Cardiovasc Drugs Ther 2016
12
25

The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation.
C Rivera, J Voipio, J A Payne, E Ruusuvuori, H Lahtinen, K Lamsa, U Pirvola, M Saarma, K Kaila. Nature 1999
25

A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
Kai Gao, Anel Tankovic, Yujia Zhang, Hirofumi Kusumoto, Jin Zhang, Wenjuan Chen, Wenshu XiangWei, Gil H Shaulsky, Chun Hu, Stephen F Traynelis,[...]. PLoS One 2017
31
25

A small molecule activator of Nav 1.1 channels increases fast-spiking interneuron excitability and GABAergic transmission in vitro and has anti-convulsive effects in vivo.
Kristen Frederiksen, Dunguo Lu, Jinhui Yang, Henrik Sindal Jensen, Jesper Frank Bastlund, Peter Hjørringgaard Larsen, Henry Liu, François Crestey, Kim Dekermendjian, Lassina Badolo,[...]. Eur J Neurosci 2017
13
25

Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome.
Dezhi Cao, Hideyuki Ohtani, Ikuo Ogiwara, Sanae Ohtani, Yukitoshi Takahashi, Kazuhiro Yamakawa, Yushi Inoue. Epilepsia 2012
29
25


Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy.
Luis F Lopez-Santiago, Yukun Yuan, Jacy L Wagnon, Jacob M Hull, Chad R Frasier, Heather A O'Malley, Miriam H Meisler, Lori L Isom. Proc Natl Acad Sci U S A 2017
44
25


Activity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis.
Benjamin Schattling, Walid Fazeli, Birgit Engeland, Yuanyuan Liu, Holger Lerche, Dirk Isbrandt, Manuel A Friese. JCI Insight 2016
13
25

GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.
Tyler Mark Pierson, Hongjie Yuan, Eric D Marsh, Karin Fuentes-Fajardo, David R Adams, Thomas Markello, Gretchen Golas, Dimitre R Simeonov, Conisha Holloman, Anel Tankovic,[...]. Ann Clin Transl Neurol 2014
143
25

Epileptic encephalopathy de novo GABRB mutations impair γ-aminobutyric acid type A receptor function.
Vaishali S Janve, Ciria C Hernandez, Kelienne M Verdier, Ningning Hu, Robert L Macdonald. Ann Neurol 2016
41
25


Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy.
Johannes R Lemke, Kirsten Geider, Katherine L Helbig, Henrike O Heyne, Hannah Schütz, Julia Hentschel, Carolina Courage, Christel Depienne, Caroline Nava, Delphine Heron,[...]. Neurology 2016
96
25

Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.
Carolien G F de Kovel, Miriam H Meisler, Eva H Brilstra, Frederique M C van Berkestijn, Ruben van 't Slot, Stef van Lieshout, Isaac J Nijman, Janelle E O'Brien, Michael F Hammer, Mark Estacion,[...]. Epilepsy Res 2014
66
25

Models for discovery of targeted therapy in genetic epileptic encephalopathies.
Snezana Maljevic, Christopher A Reid, Steven Petrou. J Neurochem 2017
23
25


Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy.
Marina Trivisano, Alessandra Terracciano, Teresa Milano, Simona Cappelletti, Nicola Pietrafusa, Enrico Silvio Bertini, Federico Vigevano, Nicola Specchio. Epilepsia 2015
14
25


How mutations in the nAChRs can cause ADNFLE epilepsy.
D Bertrand, F Picard, S Le Hellard, S Weiland, I Favre, H Phillips, S Bertrand, S F Berkovic, A Malafosse, J Mulley. Epilepsia 2002
116
25

Structure and regulation of voltage-gated Ca2+ channels.
W A Catterall. Annu Rev Cell Dev Biol 2000
25


The spectrum of SCN1A-related infantile epileptic encephalopathies.
Louise A Harkin, Jacinta M McMahon, Xenia Iona, Leanne Dibbens, James T Pelekanos, Sameer M Zuberi, Lynette G Sadleir, Eva Andermann, Deepak Gill, Kevin Farrell,[...]. Brain 2007
344
25

Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel.
K Ikeda, K Araki, C Takayama, Y Inoue, T Yagi, S Aizawa, M Mishina. Brain Res Mol Brain Res 1995
119
25

Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.
Stephan J Sanders, Xin He, A Jeremy Willsey, A Gulhan Ercan-Sencicek, Kaitlin E Samocha, A Ercument Cicek, Michael T Murtha, Vanessa H Bal, Somer L Bishop, Shan Dong,[...]. Neuron 2015
638
25

Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region.
Constanze Reutlinger, Ingo Helbig, Barbara Gawelczyk, Jose Ignacio Martin Subero, Holger Tönnies, Hiltrud Muhle, Katrin Finsterwalder, Sascha Vermeer, Rolph Pfundt, Jürgen Sperner,[...]. Epilepsia 2010
62
25


Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities.
Melinda S Martin, Karoni Dutt, Ligia A Papale, Céline M Dubé, Stacey B Dutton, Georgius de Haan, Anupama Shankar, Sergio Tufik, Miriam H Meisler, Tallie Z Baram,[...]. J Biol Chem 2010
147
25

A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.
John F Staropoli, Amel Karaa, Elaine T Lim, Andrew Kirby, Naser Elbalalesy, Stephen G Romansky, Karen B Leydiker, Scott H Coppel, Rosemary Barone, Winnie Xin,[...]. Am J Hum Genet 2012
65
25

The sodium-activated potassium channel Slack is required for optimal cognitive flexibility in mice.
Anne E Bausch, Rebekka Dieter, Yvette Nann, Mario Hausmann, Nora Meyerdierks, Leonard K Kaczmarek, Peter Ruth, Robert Lukowski. Learn Mem 2015
17
25

Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants.
Sarah E Heron, Houman Khosravani, Diego Varela, Chris Bladen, Tristiana C Williams, Michelle R Newman, Ingrid E Scheffer, Samuel F Berkovic, John C Mulley, Gerald W Zamponi. Ann Neurol 2007
127
25


Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy.
Gökce Orhan, Merle Bock, Dorien Schepers, Elena I Ilina, Stephanie Nadine Reichel, Heidi Löffler, Nicole Jezutkovic, Sarah Weckhuysen, Simone Mandelstam, Arvid Suls,[...]. Ann Neurol 2014
124
25

Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures.
Roy Ben-Shalom, Caroline M Keeshen, Kiara N Berrios, Joon Y An, Stephan J Sanders, Kevin J Bender. Biol Psychiatry 2017
104
25

GRIN2A: an aptly named gene for speech dysfunction.
Samantha J Turner, Angela K Mayes, Andrea Verhoeven, Simone A Mandelstam, Angela T Morgan, Ingrid E Scheffer. Neurology 2015
41
25


Multiple molecular mechanisms for a single GABAA mutation in epilepsy.
Christopher A Reid, Taehwan Kim, A Marie Phillips, Jun Low, Samuel F Berkovic, Bernhard Luscher, Steven Petrou. Neurology 2013
51
25

Novel HCN2 mutation contributes to febrile seizures by shifting the channel's kinetics in a temperature-dependent manner.
Yuki Nakamura, Xiuyu Shi, Tomohiro Numata, Yasuo Mori, Ryuji Inoue, Christoph Lossin, Tallie Z Baram, Shinichi Hirose. PLoS One 2013
33
25

A potassium channel mutation in neonatal human epilepsy.
C Biervert, B C Schroeder, C Kubisch, S F Berkovic, P Propping, T J Jentsch, O K Steinlein. Science 1998
795
25

Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice.
Inseon Song, Daesoo Kim, Soonwook Choi, Minjeong Sun, Yeongin Kim, Hee-Sup Shin. J Neurosci 2004
100
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.